UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2026 or ? TRANSITION REPORT PURSUANT TO...
2026 Q2 Form 10-Q
Filed with ASX ·
On 6ix: 6ix.com/news/2026-q2-form-10-q
6ix hasn’t read this filing yet.
Imricor Medical Systems, Inc. on 6ix
Earlier from Imricor Medical Systems
- Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission
- Philips Declares Compatibility with Imricor
- Q2 FY26 Results Webinar Notification
Later from Imricor Medical Systems
- 1H 2026 Investor Presentation
- Imricor U.S. Commercial Momentum Accelerates
- Imricor and Philips Launch Commercial iMR Lab Solution
- Release from Voluntary Escrow
- FDA Accepts Imricor PMA Manufacturing Module
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems